Elicio Therapeutics Inc (ELTX)
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer
Surgery Partners Inc (SGRY)
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions
Xwell Inc (XWEL)
XWELL Named Official Wellness Spa of the Orlando Magic
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
Johnson & Johnson (JNJ)
Johnson & Johnson Launches New TECNIS Odyssey Next-Generation Intraocular Lens in Europe, the Middle East, and Canada Offering Cataract Patients Precise Vision at Every Distance in Any Lighting*†‡1,6
Aptose Biosciences Inc (APTO)
Aptose Provides Corporate Updates
Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE)
Lifeist Wellness Inc. (LFSWF)
Lifeist Wellness Inc. Launches Mikras Mind-First Movement, Redefining High-Performance Excellence
OncoCyte Corporation (OCX)
Incannex Healthcare Ltd (IXHL)
Dynavax Technologies Corporation (DVAX)
New Form 8-K - DYNAVAX TECHNOLOGIES CORP Filed: 2025-06-17 AccNo: 0001193125-25-141755 Size: 383 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial …
Agenus Inc. (AGEN)
Agenus Inc. - Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
ProPhase Labs Inc. (PRPH)
ProPhase Labs Announces Successful Study Demonstrating Performance ofBE-Smart™ Test in Detecting Esophageal Cancer
Incannex Healthcare Ltd (IXHL)
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy
Agenus Inc. (AGEN)
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology